Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Molecular Cell
|
January 1, 2021
Structure of an activated DNA-PK and its implications for NHEJ
Xuemin Chen, Xiang Xu, Yun Chen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 24, 2013
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer
Martin Reck, Maciej Krzakowski, Ewa Chmielowska, et al.
Structure (London, England : 1993)
|
August 14, 2020
Cryo-EM Reveals Unanchored M1-Ubiquitin Chain Binding at hRpn11 of the 26S Proteasome
Xiang Chen, Zachary Dorris, Dan Shi, et al.
BMC Neurology
|
November 24, 2021
Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial
R Matthew Hutchison, Karleyton C Evans, Tara Fox, et al.
Mbio
|
March 29, 2022
Structural Studies Reveal the Role of Helix 68 in the Elongation Step of Protein Biosynthesis
Giuseppe Cimicata, Gil Fridkin, Tanaya Bose, et al.
Communications Biology
|
March 2, 2024
Structural dynamics of RAF1-HSP90-CDC37 and HSP90 complexes reveal asymmetric client interactions and key structural elements
Lorenzo I Finci, Mayukh Chakrabarti, Gulcin Gulten, et al.
Cell
|
October 7, 2017
Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex
Tai Wei Guo, Alberto Bartesaghi, Hui Yang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 19, 2019
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054
Miroslaw Brys, Laura Fanning, Serena Hung, et al.
Neurology
|
February 5, 2024
Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial
R Matthew Hutchison, Kyle Fraser, Minhua Yang, et al.
The New England Journal of Medicine
|
August 3, 2022
Trial of Cinpanemab in Early Parkinson's Disease
Anthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Molecular Cell
|
January 1, 2021
Structure of an activated DNA-PK and its implications for NHEJ
Xuemin Chen, Xiang Xu, Yun Chen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 24, 2013
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer
Martin Reck, Maciej Krzakowski, Ewa Chmielowska, et al.
Structure (London, England : 1993)
|
August 14, 2020
Cryo-EM Reveals Unanchored M1-Ubiquitin Chain Binding at hRpn11 of the 26S Proteasome
Xiang Chen, Zachary Dorris, Dan Shi, et al.
BMC Neurology
|
November 24, 2021
Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial
R Matthew Hutchison, Karleyton C Evans, Tara Fox, et al.
Mbio
|
March 29, 2022
Structural Studies Reveal the Role of Helix 68 in the Elongation Step of Protein Biosynthesis
Giuseppe Cimicata, Gil Fridkin, Tanaya Bose, et al.
Communications Biology
|
March 2, 2024
Structural dynamics of RAF1-HSP90-CDC37 and HSP90 complexes reveal asymmetric client interactions and key structural elements
Lorenzo I Finci, Mayukh Chakrabarti, Gulcin Gulten, et al.
Cell
|
October 7, 2017
Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex
Tai Wei Guo, Alberto Bartesaghi, Hui Yang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 19, 2019
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054
Miroslaw Brys, Laura Fanning, Serena Hung, et al.
Neurology
|
February 5, 2024
Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial
R Matthew Hutchison, Kyle Fraser, Minhua Yang, et al.
The New England Journal of Medicine
|
August 3, 2022
Trial of Cinpanemab in Early Parkinson's Disease
Anthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.
Page
of 2